Leading Scientific Experts to Convene in Washington, D.C. as Cases of Type 1 Diabetes Rise
Parents and Clinicians to Learn About the Challenges and Opportunities of Raising a Child With Type 1 Diabetes at Free Juvenile Diabetes Research Foundation Summit
Washington, DC (PRWEB) January 24, 2011
On Saturday, January 29th, hundreds of parents and clinicians from up and down the East Cost will have the opportunity to hear first-hand from some of the country’s most prominent researchers about the latest developments in the prevention, management and cure of type 1 diabetes. The Type 1 Research Summit is sponsored by the Juvenile Diabetes Research Foundation’s Capitol Chapter and will be held 10 a.m. ““ 3 p.m. at the Bethesda North Marriott Hotel and Conference Center in Maryland. Registration is required.
Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. There is no known way to prevent type 1 diabetes and no cure. People with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump – each day, every day of their lives. Even with this intensive care regimen, insulin is not a cure for diabetes, nor does it prevent devastating complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
Diabetes of all types continues to grow at an alarming rate – in the last 30 years, the number of people with diabetes has skyrocketed to about 24 million people in the United States alone, including as many as three million Americans affected by type 1 diabetes. The cost of diabetes is staggering – one out of every five health care dollars is spent caring for someone with diagnosed diabetes, and one out of every three Medicare dollars is attributed to diabetes. The national price tag for diabetes is at an astounding $174 billion per year and that cost is estimated to almost triple in the next 25 years.
Even with treatments available today, tight blood sugar control remains a challenge and daily struggle for those living with type 1 diabetes. The majority of people living with the disease are not achieving recommended target levels.
“The JDRF Research Summit offers access to information from leading experts in diabetes prevention, treatment and awareness. Each brings a unique perspective, from physicians to scientists and congressional staffers, to medical journalists,” said Diana DeGette (D-CO), Co-Chair of the Congressional Diabetes Caucus.
One of the highlights of the Summit will be the latest news on the development of an artificial pancreas. JDRF launched the Artificial Pancreas Project in 2005 to speed the development of automated diabetes management systems. A self-regulating system, the artificial pancreas would be able to sense sugar levels continuously and automatically release the right amount of insulin at the right times – eliminating the need for multiple blood tests, insulin injections and therefore lifting the daily burden associated with managing diabetes.
“An artificial pancreas, essentially a device that would both measure blood sugar and dispense appropriate amounts of insulin to keep levels in optimal range, would take much of the guesswork out of daily management of the disease,” said Dr. Aaron Kowalski, Assistant Vice President of Treatment Therapies at JDRF who will be speaking at the Summit. “In the long-run, controlled blood sugar levels will help to lessen or avert the devastating complications from type 1 diabetes.”
Other speakers include Dan Hurley, author of Diabetes Rising; Henry Rodriguez, M.D.(University of South Florida Diabetes Center), who will speak about the challenges and opportunities of raising a child with type 1; Mark Atkinson, PhD, from the Network of Pancreatic Organ Donors with Diabetes (nPOD) and Director of the Diabetes Center of Excellence at the University of Florida; Ed Damiano, PhD, of Boston University, where one of the artificial pancreas trials is taking place; Jerry Palmer, M.D. (University of Washington) who will talk about the DiaPrevent GAD study which is looking at whether the Diamyd vaccine can preserve insulin function; and Bill Parsons, Legislative Director to Congressman Chris Van Hollen (D-MD).
Special thanks to Diamyd for their support as a Vision Sponsor of the 2011 JDRF Summit. For more information about the Summit, visit jdrfcapitol.org/summit or call 202-371-0044.
JDRF is the leader in research leading to a cure for type 1 diabetes in the world. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Since its founding in 1970 by parents of children with type 1 diabetes, JDRF has awarded more than $1.4 billion to diabetes research, including more than $100 million in 22 countries in FY2009. For more information, please visit http://www.jdrf.org/
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2011/01/prweb4987374.htm